Home
About
Publications Trends
Recent Publications
Expert Search
Archive
cachexia
How Common is Cachexia in Cancer Patients?
Cachexia is quite prevalent among cancer patients, affecting approximately 50-80% of those with advanced cancer. It is particularly common in cancers of the pancreas, lung, and gastrointestinal tract.
Frequently asked queries:
What is Cachexia?
How Common is Cachexia in Cancer Patients?
What Causes Cachexia in Cancer Patients?
What are the Symptoms of Cachexia?
How is Cachexia Diagnosed?
What are the Treatment Options for Cachexia?
Are There Any Emerging Therapies for Cachexia?
How Does Cachexia Impact Cancer Prognosis?
Can Cachexia be Prevented?
What Future Developments Can We Expect in Fluorescence Microscopy for Cancer Research?
What are the Resources Available for Cancer Patients?
What are the Goals of Cancer Treatment?
Why is Epidemiology Important in Cancer Research?
How Does Cancer Impact Daily Life?
How Does TGF-β Promote Tumor Progression?
What are the key requirements for data protection under GDPR?
How Can MyChart Help Cancer Patients?
What is the Importance of Genomic Data?
What Are the Psychological Symptoms Associated with Cancer?
How Can Physical Activity Improve QoL?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe